Delos Capital Overview
Life sciences investment firm that partners with teams pursuing breakthrough medicines that improve the lives of patients. The firm includes a collaborative, global team of seasoned biotech investors, company-builders, operators, and industry analysts, that aim to serve the companies into which they invest by bringing both capital and substantive biotech expertise. The firm had designed, built, financed, and supported both novel platforms and approved medicines. They are guided by the desire to enable high-value medicines, and so they work across therapeutic areas in a modality-agnostic manner, partnering with companies ranging from discovery platforms to those in clinical development.
Latest News
No news articles.
Delos Capital Business
Sector
—Target Customer
—Core Technology
—Delos Capital Financials
Delos Capital Lifecycle
Delos Capital News
0 articlesNo news articles.
Delos Capital Team
No team members listed.
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
Delos Capital Internal
Recent Updates
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 16/100 |
| Missing | funding stage, product stage, sector, founding year, founding month, number of employees, tags, invite member, business model, address, tag line, video or image, funding rounds, news, markets, external profiles, not claimed |
| Creator | Ortal Wein |
| Creator email | ortalw@sncentral.org |
| Last update | 2024-09-16T00:00:00.000Z |
| Created | 2024-09-16T00:00:00.000Z |